Table 4. Effect of intervention on AM treatment coverage assessed by cross-sectional study.
| Baseline | Endline | |||||||
|---|---|---|---|---|---|---|---|---|
| Comparison | Intervention | Comparison | Intervention | Δ (pp)a | 95% CI | p-Value | ||
| Children with AM at the time of the survey | n = 172 | n = 188 | n = 169 | n = 156 | ||||
| Treatment coverage (primary outcome)b | 30 (17%) | 23 (12%) | 17 (10%) | 8 (5.1%) | −4.3 | (−10, 1.5) | 0.14* | |
| Received any type of AM treatment productc | 31 (18%) | 24 (13%) | 17 (10%) | 10 (6.4%) | −3.4 | (−9.1, 2.2) | 0.24 | |
| Children with MAM at the time of the survey | n = 141 | n = 155 | n = 128 | n = 123 | ||||
| Treatment coverageb | 26 (18%) | 19 (12%) | 14 (11%) | 7 (5.7%) | −4.9 | (−12, 2.3) | 0.19 | |
| Received a MAM treatment product | 17 (12%) | 7 (4.5%) | 12 (9.4%) | 5 (4.1%) | −4.6 | (−11, 2.0) | 0.18 | |
| Received a SAM treatment product | 14 (9.9%) | 16 (10%) | 4 (3.1%) | 2 (1.6%) | −2.3 | (−6.7, 2.2) | 0.32 | |
| Children with SAM at the time of the survey | n = 31 | n = 33 | n = 41 | n = 33 | ||||
| Treatment coverageb | 4 (13%) | 4 (12%) | 3 (7.3%) | 1 (3.0%) | −4.7 | (−15, 5.6) | 0.37 | |
| Received any type of AM treatment productc | 5 (16%) | 5 (15%) | 3 (7.3%) | 3 (9.1%) | −2.1 | (−12, 7.9) | 0.67 | |
Data are n(%) or mean ± SD. Abbreviations: AM, acute malnutrition; CI, confidence interval; ICC, intracluster correlation coefficient; MAM, moderate acute malnutrition; pp, percentage point; SAM, severe acute malnutrition.
*Not statistically significant after correcting for multiple testing of primary outcomes, using a pcritical = 0.025 calculated using the Benjamini–Hochberg method. ICC for primary outcomes are presented in S2 Table.
aDifference between intervention and comparison arm expressed in percentage point analyzed using a mixed-effect linear probability regression model with health center as random effect and sampling strata, health district, child sex, whether the child was the first liveborn, child age, the cluster means of the outcome at baseline, and intervention as fixed effects.
bTreatment coverage is defined by MAM children receiving a MAM or SAM treatment product and SAM children receiving a SAM treatment product in the past month.
cAny type of AM treatment product refers to MAM and SAM treatment products used by the health services.